SOLUBLE ST2 IS AFFECTED BY PULMONARY HYPERTENSION SEVERITY IN PATIENTS UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
نویسندگان
چکیده
منابع مشابه
Drug Therapy in Patients with Chronic Thromboembolic Pulmonary Hypertension
Background: Chronic Thromboembolic Pulmonary Hypertension (CTEPH) results from the obstruction of predominantly major pulmonary vessels by organized blood clots and is one of the causes of pulmonary hypertension. The disease is still underdiagnosed and the true prevalence is not clear. The objective of this study was to determine the clinical characteristics and current management of patients w...
متن کاملAtherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling
Interleukin (IL)-33 is a cytokine of the IL-1 family, which signals through the ST2 receptor. Previous work demonstrated that the systemic administration of recombinant IL-33 reduces the development of atherosclerosis in apolipoprotein E-deficient (ApoE(-/-)) mice by inducing a Th1-to-Th2 shift. The objective of our study was to examine the role of endogenous IL-33 and ST2 in atherosclerosis. A...
متن کاملCardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome
Metabolic syndrome (MS) is a multifactorial disease that can affect clinical outcomes in patients treated by Cardiac Resynchronization Therapy with a defibrillator (CRT-d).Ninety-one patients received a CRT-d. According to clinical diagnosis, the study population was divided into 46 MS (cases) versus 45 no MS (controls) patients. These patients were followed by clinical, instrumental assessment...
متن کامل[Cardiac resynchronization therapy: is there any news?].
Mailing address: Ana Clara Tude Rodrigues • Ecocardiografia – InRad – HCFMUSP – Av. Enéas de Carvalho Aguiar, 255 Cerqueira César – 05403-000 São Paulo, SP Brazil E-mail: [email protected] Manuscript received June 11, 2009; revised manuscript received June 16, 2009; accepted July 28, 2009.
متن کاملHow many patients need cardiac resynchronization therapy?
For patients with moderate or severe heart failure who have evidence of cardiac dyssynchrony there is overwhelming evidence that cardiac resynchronization therapy (CRT) improves symptoms substantially, reduces morbidity, and prolongs life. The CARE-HF programme demonstrated that CRT reduced all-cause mortality by 40% and cardiovascular mortality by about 45%. The COMPANION trial, which was stop...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2016
ISSN: 0735-1097
DOI: 10.1016/s0735-1097(16)30860-9